Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
The US Food and Drug Administration (FDA) has approved the immunotherapy avelumab in combination with the tyrosine kinase inhibitor axitinib for the first-line treatment of patients with advanced renal cell carcinoma (RCC). The…
According to the Associated Press’ search of a U.S. government database, six of the eight currently registered clinical trials studying deep brain stimulation (DBS) for addiction treatment are…
Researchers in Australia are developing new approaches to blocking inflammasomes, the multiprotein molecular complex that stimulates the body’s inflammatory immune response and drives the progression of Parkinson’s disease…
The enormously popular video game Fortnite gives rise to hours-long marathon playing sessions—and now there’s evidence that it creates health problems in young players as well. According to…
A new cancer treatment combines conventional chemotherapy drugs with a digital sensor in a single capsule. Developed by biotech company Proteus Digital Health, the “digital medicine solution” communicates…
Researchers may have cracked an important code in the influenza virus, one that may lead to the development of flu vaccines that remain potent for up to 10…
Trees may hold the key to new discoveries about cancer and tumor formation. Fast-growing poplar trees were originally examined for potential applications in renewable energy, but were accidentally…
A research team at University of Massachusetts is investigating a recently identified type of body fat that may have beneficial effects in the body. Known as “beige fat,”…
